Clinicopathologic and biomolecular features of interval colorectal cancers in Korean patients: A KASID multicenter prospective study

doi:10.3748/wjg.127120

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 33, Issue 2

This Article

(2)

(0)

(154)

Peer-Review Report of This Article

Supplementary Materials of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Jan 14, 2027; 33(2): 127120
Published online Jan 14, 2027. doi: 10.3748/wjg.127120

Full Size Figure Download Figure

Figure 2 Cumulative survival rates in patients with interval colorectal cancer and sporadic colorectal cancer.

Citation: Song JH, Shin JE, Kim DS, Lee YJ, Yang HC, Kim KO, Kim JH, Kang GH, Shim SR, Huh KC. Clinicopathologic and biomolecular features of interval colorectal cancers in Korean patients: A KASID multicenter prospective study. World J Gastroenterol 2027; 33(2): 127120
URL: https://www.wjgnet.com/1007-9327/full/v33/i2/127120.htm
DOI: https://dx.doi.org/10.3748/wjg.127120

Song JH, Shin JE, Kim DS, Lee YJ, Yang HC, Kim KO, Kim JH, Kang GH, Shim SR, Huh KC. Clinicopathologic and biomolecular features of interval colorectal cancers in Korean patients: A KASID multicenter prospective study. World J Gastroenterol 2027; 33(2): 127120 [DOI: 10.3748/wjg.127120]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.